Search Results - "Banerji, D."

Lithology and reservoir properties of the Delaware Mountain Group of the Delaware Basin and implications for saltwater disposal and induced seismicity by Smye, Katie, Banerji, D. Amy, Eastwood, Ray, McDaid, Guin, Hennings, Peter

“…Deepwater siliciclastic deposits of the Delaware Mountain Group (DMG) in the Delaware Basin (DB) are the primary interval for disposal of hydraulic fracturing…”
Get full text

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD by Zhong, Nanshan, Wang, Changzheng, Zhou, Xiangdong, Zhang, Nuofu, Humphries, Michael, Wang, Linda, Thach, Chau, Patalano, Francesco, Banerji, Donald

“…The current Global initiative for chronic Obstructive Lung Disease (GOLD) treatment strategy recommends the use of one or more bronchodilators according to the…”
Get full text

The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD by Anzueto, Antonio R, Vogelmeier, Claus F, Kostikas, Konstantinos, Mezzi, Karen, Fucile, Sebastian, Bader, Giovanni, Shen, Steven, Banerji, Donald, Fogel, Robert

“…Endpoints that evaluate deterioration rather than improvement of disease may have clinical utility in COPD. In this analysis, we compared the effects of…”
Get full text

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study by Wedzicha, Jadwiga A, Zhong, Nanshan, Ichinose, Masakazu, Humphries, Michael, Fogel, Robert, Thach, Chau, Patalano, Francesco, Banerji, Donald

“…The FLAME study demonstrated that indacaterol/glycopyrronium (IND/GLY), the fixed-dose combination of a long-acting β -agonist (LABA, IND) and a long-acting…”
Get full text

Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients by Kostikas, Konstantinos, Mackay, Alexander J, Vogelmeier, Claus F, Frent, Stefan-Marian, Gupta, Pritam, Banerji, Donald, Patalano, Francesco, Pfister, Pascal J, Wedzicha, Jadwiga A

“…Background: Chronic obstructive pulmonary disease (COPD) exacerbations are difficult outcomes to measure in clinical trials. It would be valuable to be able to…”
Get full text

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum] by Hashimoto, Shu, Ikeuchi, Hisataro, Murata, Shujiro, Kitawaki, Tetsuji, Ikeda, Kimitoshi, Banerji, Donald

“…Hashimoto S, Ikeuchi H, Murata S, Kitawaki T, Ikeda K, Banerji D. Int J Chron Obstruct Pulmon Dis. 2016;11:2543–2551. On page 2547, Figure 5, x-axis, the dose…”
Get full text

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study by Vogelmeier, Claus F, Chapman, Kenneth R, Miravitlles, Marc, Roche, Nicolas, Vestbo, Jørgen, Thach, Chau, Banerji, Donald, Fogel, Robert, Patalano, Francesco, Olsson, Petter, Kostikas, Konstantinos, Wedzicha, Jadwiga A

“…The FLAME study compared once-daily indacaterol/glycopyrronium (IND/GLY) 110/50 μg with twice-daily salmeterol/fluticasone (SFC) 50/500 μg in symptomatic…”
Get full text

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study by Hashimoto, Shu, Ikeuchi, Hisataro, Murata, Shujiro, Kitawaki, Tetsuji, Ikeda, Kimitoshi, Banerji, Donald

“…COPD-related deaths are increasing in Japan, with ~5.3 million people at risk. The SHINE was a 26-week, multicenter, randomized, double-blind, parallel-group…”
Get full text

Development of autonomous mobile robot with manipulator for manufacturing environment by Datta, S., Ray, R., Banerji, D.

“…This paper describes the developmental effort involved in prototyping the first indigenous autonomous mobile robot, AMR, with a manipulator for carrying out…”
Get full text

Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma by Lipworth, Brian J, Kaliner, Michael A, LaForce, Craig F, Baker, James W, Kaiser, Harold B, Amin, Dilip, Kundu, Sudeep, Williams, James E, Engelstaetter, Renate, Banerji, Donald D

“…Despite their proven efficacy in the treatment and prevention of asthma exacerbations, current inhaled corticosteroids carry safety concerns, especially…”
Get more information

Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma by Szefler, Stanley, Rohatagi, Shashank, Williams, James, Lloyd, Mark, Kundu, Sudeep, Banerji, Donald

“…Inhaled corticosteroids (ICSs) reduce local airway inflammation, which is an underlying cause of asthma symptoms. However, potential systemic side effects…”
Get more information

Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis by Vogelmeier, Claus, Zhong, Nanshan, Humphries, Michael J, Mezzi, Karen, Fogel, Robert, Bader, Giovanni, Patalano, Francesco, Banerji, Donald

“…Indacaterol/glycopyrronium (IND/GLY) is approved for maintenance treatment of adult patients with COPD. This post hoc analysis explored the efficacy and safety…”
Get full text

Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study [Corrigendum] by Dahl, Ronald, Jadayel, Dalal, Alagappan, Vijay, Chen, Hungta, Banerji, Donald

“…Dahl R, Jadayel D, Alagappan VKT, Chen H, Banerji D. Int J Chron Obstruct Pulmon Dis. 2013;8:501-508.On page 501, note that in the Results section of the…”
Get full text

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum] by Buhl, Roland, Banerji, Donald

“…Buhl R, Banerji D. Int J Chron Obstruct Pulmon Dis. 2012;7:729–741. On page 737 in the first paragraph of the "Safety" section, the final sentence "Serious…”
Get full text

Room-temperature hydrogen sensor based on palladium nanowires by Atashbar, M.Z., Banerji, D., Singamaneni, S.

“…Palladium (Pd) nanowires, synthesized by template-nanomanufacturing techniques, has been studied for hydrogen gas-sensing applications at room temperature. In…”
Get full text

Giant vestibular schwannomas: focusing on the differences between the solid and the cystic variants by Mehrotra, N., Behari, S., Pal, L., Banerji, D., Sahu, R. N., Jain, V. K.

“…In vestibular schwannomas (VS), the tumour size, as well as the size of the cystic component, have a considerable bearing on the outcome. This study addresses…”
Get full text

Politics of rural health in India by Banerji, D

“…The setting up of the National Rural Health Mission is yet another political move by the present government of India to make yet another promise to the long…”
Get full text

Protective efficacy of a monovalent oral type 1 poliovirus vaccine by Puliyel, Jacob, Sathyamala, C, Banerji, D

Get full text

Intracranial aneurysms in patients 18 years of age or under, are they different from aneurysms in adult population? by Krishna, H, Wani, A A, Behari, S, Banerji, D, Chhabra, D K, Jain, V K

“…Intracranial aneurysms are extremely uncommon in the first two decades of life. This study was undertaken to assess the clinicoradiological features and…”
Get full text

Evidence-based National Vaccine Policy by Madhavi, Y, Puliyel, Jacob M, Mathew, Joseph L, Raghuram, N, Phadke, Anant, Shiva, Mira, Srinivasan, S, Paul, Yash, Srivastava, R N, Parthasarathy, A, Gupta, Sunil, Ranga, Udaykumar, Lakshmi, V Vijaya, Joshi, Nayana, Nath, Indira, Gulhati, C M, Chatterjee, Prabir, Jain, Anuradha, Priya, Ritu, Dasgupta, Rajib, Sridhar, S, Dabade, Gopal, Gopakumar, K M, Abrol, Dinesh, Santhosh, M R, Srivastava, Sadhana, Visalakshi, S, Bhargava, Anurag, Sarojini, N B, Sehgal, Devinder, Selvaraj, Sakthivel, Banerji, D

“…India has over a century old tradition of development and production of vaccines. The Government rightly adopted self-sufficiency in vaccine production and…”
Get full text